Publication date: Dec 09, 2024

These distinctive features pave the way for vaccinating populations in developing countries and the future development of simpler, more effective, and less expensive vaccines. This nano-vaccine, a 200-nanometer particle, effectively trains the immune system against all common COVID-19 variants, performing as well as existing vaccines. Unlike other vaccines, it is conveniently administered as a nasal spray and does not require a cold supply chain or ultra-cold storage. A new nano-vaccine developed by TAU and the University of Lisbon offers a needle-free, room-temperature-storable solution against COVID-19, targeting all key variants effectively. The groundbreaking study was featured on the cover of the prestigious journal Advanced Science.

Semantics